Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs leflunomide added to methotrexate in refractory rheumatoid arthritis (Phase IV)
KCT0000781Phase 4Recruiting
- Sponsor
- Astellas Pharma
- Start
- May 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus, leflunomide in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started May 2013; status: recruiting.
02
Drugs
tacrolimusleflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on KCT0000781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000781.